Market Overview:
The global specialty drug distribution market is expected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and growing demand for specialty drugs. By type, the oncology segment is expected to account for the largest share of the global specialty drug distribution market in 2018. This segment is also projected to grow at a high CAGR during the forecast period. By application, retail is expected to account for the largest share of the global market in 2018.
Product Definition:
A specialty drug distribution is a company that specializes in the distribution of high-cost prescription drugs to hospitals, pharmacies, and other healthcare providers. Specialty drug distributors are important because they play a key role in getting these expensive drugs to the people who need them.
Oncology:
Oncology is the study of cancer, which is a disease of the cells caused by abnormal growth and division. The different types of cancers include lung, breast, colorectal, prostate and liver cancer. Cancer generally leads to one or more symptoms such as pain in a part of the body, vomiting blood or losing hair.
Rheumatoid Arthritis:
Rheumatoid arthritis (RA) is a chronic disorder characterized by joint inflammation. It most commonly affects the wrist, shoulder, and neck. The cause of this disease is still unknown; however, research has shown that it may be triggered by an infection in the lining of the immune system.
Application Insights:
The retail segment held the largest share of over 70.0% in 2017. The growth can be attributed to the increasing number of specialty pharmacies and growing awareness among patients regarding access to quality medicines at affordable prices. Specialty drug distribution through retail pharmacies is expected to grow significantly owing to their ability to offer a wider range of products with greater convenience, as compared with other modes of delivery such as hospital-based or home healthcare services.
Pharmacies are anticipated register significant growth during the forecast period due specialties drugs being highly dependent on dosage and frequency for its effectiveness, thus making it more convenient for patients seeking advice from pharmacists about proper medication dosages and usage instructions before starting any new treatment course or medication regimen.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of specialty pharmacies, which are responsible for delivering high-quality specialty medicines to patients at an affordable price, is one of the major factors driving this regional market. In addition, increasing demand for generic drugs due to regulatory changes and rising healthcare expenditure is expected to further propel growth over the forecast period.
Asia Pacific is estimated to be fastest-growing region during the forecast period owing to growing patient awareness levels regarding available treatments along with rising disposable income in emerging countries such as China and India. Moreover, government initiatives encouraging R&D activities are likely boost regional growth over the next eight years (from 2018 to 2030).
Growth Factors:
- Increasing incidence of chronic diseases: The prevalence of chronic diseases is increasing at an alarming rate across the globe. This is primarily because of the changing lifestyle and dietary habits of people. The specialty drug distribution market is expected to benefit from this trend as it offers specialized drugs and services for the treatment of various chronic diseases.
- Rising demand for orphan drugs: There are a number of rare or orphan diseases that affect a small population worldwide. The development and commercialization of orphan drugs has become a priority for many pharmaceutical companies in recent years. This is expected to drive the growth of the specialty drug distribution market in the coming years.
- Technological advancements: Drug manufacturers are constantly investing in research and development to develop new therapies that can improve patient outcomes while reducing costs associated with treatment procedures. This is likely to result in increased demand for specialty drugs, which will benefit players operating in the specialty drug distribution market space .
Scope Of The Report
Report Attributes
Report Details
Report Title
Specialty Drug Distribution Market Research Report
By Type
Oncology, Rheumatoid Arthritis, Multiple Sclerosis, Hemophilia, Specialty Drug Distributio
By Application
Retail, Home Health, Clinics, Pharmacies
By Companies
Amerisource, Mckesson, Cardinal Health, PHOENIX, Medipal Holdings, Alliance Healthcare, Celesio, Sinopharm, Accredo, Shanghai Pharma, Anda, Jointown, Max Pharma, Avella, Specialty Drug Distributio
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Specialty Drug Distribution Market Report Segments:
The global Specialty Drug Distribution market is segmented on the basis of:
Types
Oncology, Rheumatoid Arthritis, Multiple Sclerosis, Hemophilia, Specialty Drug Distributio
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Retail, Home Health, Clinics, Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amerisource
- Mckesson
- Cardinal Health
- PHOENIX
- Medipal Holdings
- Alliance Healthcare
- Celesio
- Sinopharm
- Accredo
- Shanghai Pharma
- Anda
- Jointown
- Max Pharma
- Avella
- Specialty Drug Distributio
Highlights of The Specialty Drug Distribution Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oncology
- Rheumatoid Arthritis
- Multiple Sclerosis
- Hemophilia
- Specialty Drug Distributio
- By Application:
- Retail
- Home Health
- Clinics
- Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Specialty Drug Distribution Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Specialty drug distribution is the process of getting a medication to patients who need it. This can be done through pharmacies, hospitals, or other medical facilities.
Some of the key players operating in the specialty drug distribution market are Amerisource, Mckesson, Cardinal Health, PHOENIX, Medipal Holdings, Alliance Healthcare, Celesio, Sinopharm, Accredo, Shanghai Pharma, Anda, Jointown, Max Pharma, Avella, Specialty Drug Distributio.
The specialty drug distribution market is expected to grow at a compound annual growth rate of 7.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Specialty Drug Distribution Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Specialty Drug Distribution Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Specialty Drug Distribution Market - Supply Chain
4.5. Global Specialty Drug Distribution Market Forecast
4.5.1. Specialty Drug Distribution Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Specialty Drug Distribution Market Size (000 Units) and Y-o-Y Growth
4.5.3. Specialty Drug Distribution Market Absolute $ Opportunity
5. Global Specialty Drug Distribution Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Specialty Drug Distribution Market Size and Volume Forecast by Type
5.3.1. Oncology
5.3.2. Rheumatoid Arthritis
5.3.3. Multiple Sclerosis
5.3.4. Hemophilia
5.3.5. Specialty Drug Distributio
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Specialty Drug Distribution Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Specialty Drug Distribution Market Size and Volume Forecast by Application
6.3.1. Retail
6.3.2. Home Health
6.3.3. Clinics
6.3.4. Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Specialty Drug Distribution Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Specialty Drug Distribution Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Specialty Drug Distribution Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Specialty Drug Distribution Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Specialty Drug Distribution Demand Share Forecast, 2019-2026
9. North America Specialty Drug Distribution Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Specialty Drug Distribution Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Specialty Drug Distribution Market Size and Volume Forecast by Application
9.4.1. Retail
9.4.2. Home Health
9.4.3. Clinics
9.4.4. Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Specialty Drug Distribution Market Size and Volume Forecast by Type
9.7.1. Oncology
9.7.2. Rheumatoid Arthritis
9.7.3. Multiple Sclerosis
9.7.4. Hemophilia
9.7.5. Specialty Drug Distributio
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Specialty Drug Distribution Demand Share Forecast, 2019-2026
10. Latin America Specialty Drug Distribution Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Specialty Drug Distribution Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Specialty Drug Distribution Market Size and Volume Forecast by Application
10.4.1. Retail
10.4.2. Home Health
10.4.3. Clinics
10.4.4. Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Specialty Drug Distribution Market Size and Volume Forecast by Type
10.7.1. Oncology
10.7.2. Rheumatoid Arthritis
10.7.3. Multiple Sclerosis
10.7.4. Hemophilia
10.7.5. Specialty Drug Distributio
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Specialty Drug Distribution Demand Share Forecast, 2019-2026
11. Europe Specialty Drug Distribution Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Specialty Drug Distribution Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Specialty Drug Distribution Market Size and Volume Forecast by Application
11.4.1. Retail
11.4.2. Home Health
11.4.3. Clinics
11.4.4. Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Specialty Drug Distribution Market Size and Volume Forecast by Type
11.7.1. Oncology
11.7.2. Rheumatoid Arthritis
11.7.3. Multiple Sclerosis
11.7.4. Hemophilia
11.7.5. Specialty Drug Distributio
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Specialty Drug Distribution Demand Share, 2019-2026
12. Asia Pacific Specialty Drug Distribution Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Specialty Drug Distribution Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Specialty Drug Distribution Market Size and Volume Forecast by Application
12.4.1. Retail
12.4.2. Home Health
12.4.3. Clinics
12.4.4. Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Specialty Drug Distribution Market Size and Volume Forecast by Type
12.7.1. Oncology
12.7.2. Rheumatoid Arthritis
12.7.3. Multiple Sclerosis
12.7.4. Hemophilia
12.7.5. Specialty Drug Distributio
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Specialty Drug Distribution Demand Share, 2019-2026
13. Middle East & Africa Specialty Drug Distribution Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Specialty Drug Distribution Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Specialty Drug Distribution Market Size and Volume Forecast by Application
13.4.1. Retail
13.4.2. Home Health
13.4.3. Clinics
13.4.4. Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Specialty Drug Distribution Market Size and Volume Forecast by Type
13.7.1. Oncology
13.7.2. Rheumatoid Arthritis
13.7.3. Multiple Sclerosis
13.7.4. Hemophilia
13.7.5. Specialty Drug Distributio
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Specialty Drug Distribution Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Specialty Drug Distribution Market: Market Share Analysis
14.2. Specialty Drug Distribution Distributors and Customers
14.3. Specialty Drug Distribution Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Amerisource
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Mckesson
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Cardinal Health
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. PHOENIX
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Medipal Holdings
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Alliance Healthcare
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Celesio
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Sinopharm
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Accredo
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Shanghai Pharma
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Anda
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Jointown
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Max Pharma
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Avella
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Specialty Drug Distributio
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook